SCHEMBL18894185

SCHEMBL18894185

CNc1c(C(F)(F)F)ccc2c1n[c]n2F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18894119 0.80 HSD11B1 (0.30) —
SCHEMBL18894094 0.76 GRM2 (0.40) —
SCHEMBL18894172 0.75 — —
SCHEMBL18894087 0.62 RORC (0.30) —
SCHEMBL23099859 0.60 RAPGEF4 (0.33) —
SCHEMBL27349731 0.59 GRIN2D (0.36) —
SCHEMBL21614302 0.59 KIF11 (0.33) —
SCHEMBL31131322 0.57 CYP3A4 (0.40) —
SCHEMBL25804770 0.57 CYP3A4 (0.40) —
SCHEMBL25253608 0.57 CYP3A4 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11136310-B2 Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors UCB Biopharma SRL (BE) 2021-10-05 — — US disclosed
US-20200283416-A1 IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS CELLTECH R&D LIMITED (GB) 2020-09-10 — — US disclosed
EP-3380464-A1 IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS UCB Biopharma SPRL (BE) 2018-10-03 — — EP disclosed
WO-2017089453-A1 IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS UCB BIOPHARMA SPRL (BE) 2017-06-01 — — WO disclosed
Send feedback